Swedish investment company Fidelio Capital has bought the European veterinary business of research-based biopharmaceutical company ALK and all associated veterinary products (Artuvetrin) for an undisclosed sum.

The deal, effective from 1 January, will see ALK – a worldwide market leader in allergen-specific immunotherapy – continue to operate under the name ArtuVet Animal Health BV.

ArtuVet Animal Health BV logoFounded in 1923, the company is best known for manufacturing the only licensed intradermal allergy test and allergen specific immunotherapy for dogs in Europe (licensed in the Netherlands).

Business as usual

Other than the change of name and ownership, the company says little else will change.

An official statement to the veterinary profession read: “The production of all Artuvetrin products (Artuvetrin Therapy, Artuvetrin Serum Test and Artuvetrin Skin Test) will be continued in Lelystad, the Netherlands. All contact persons and details will not change. Please be assured Artuvet will continue to supply the Artuvetrin products and offer you and your clients the utmost quality and service.

“We are looking forward to a successful future together with you and we will continue to give the best support to your atopic patients.”

View your activity >

Leave a Reply

Be the First to Comment!

Notify of


related content

The practice in Bishops Waltham, Hampshire celebrated with demonstrations, games and quizzes, as well as raising money for charity.

3 mins

Ian Ramsey, Susanna Spence and Emma Roberts having all been involved in a desoxycortone pivalate clinical trial, provide a review of hypoadrenocorticism, as well as suggestions for management in dogs.

29 mins

One of the UK's leading telephone answering specialists has revealed the start of the week is the worst period for missed telephone calls.

4 mins

James Oxley and Tamara Montrose take a look at several cases and research studies into the causes and factors related to cats falling from tall structures, and the resulting injuries sustained.

11 mins

Owen Atkinson discusses various approaches towards managing this common pernicious disease affecting the bovine foot.

22 mins

Sebastien Behr looks at signs, diagnosis and treatment of masses found in the pituitary gland.

7 mins